Publications by authors named "K Hemminki"

A double primary colorectal cancer (CRC) in a familial setting signals a high risk of CRC. In order to identify novel CRC susceptibility genes, we whole-exome sequenced germline DNA from nine persons with a double primary CRC and a family history of CRC. The detected variants were processed by bioinformatics filtering and prioritization, including STRING protein-protein interaction and pathway analysis.

View Article and Find Full Text PDF

Prognostic value of T-cells between primary colorectal cancer (pCRC) and its paired synchronous and metachronous liver metastasis (LM) is underinvestigated and is the subject of the present study. We enrolled into this retrospective cohort study patients, who underwent resection of both pCRC and synchronous LM (N = 55) or metachronous LM (N = 44). After immunohistochemical staining for CD3+, CD8+, and CD45R0+ whole slides were scanned and T-cell densities were quantified using QuPath software in tumor center (TC), inner margin (IM), outer margin (OM), and peritumor zone (PT) of pCRC and LM.

View Article and Find Full Text PDF
Article Synopsis
  • Thyroid cancer (TC) has various histological types that impact patient survival differently, with improvements in relative survival rates noted in Sweden between 1999 and 2018.
  • Female patients generally have better survival rates compared to males and certain types, like follicular and oncocytic, show particularly high 5-year relative survival rates, though anaplastic cancer remains significantly more lethal.
  • Urgent diagnosis and treatment are critical for anaplastic TC due to its poor survival outcomes, highlighting the need for dedicated research and improved treatment pathways similar to those implemented in Denmark.
View Article and Find Full Text PDF

Background: Chronic lymphocytic leukemia (CLL) is a common hematological malignancy with highly variable clinical presentation. Many patients never require any treatment but for the others, chemotherapy, immunochemotherapy, and newer targeted therapies have changed the treatment landscape. Diagnostic age influences the applied treatment, and we thus wanted to analyze age-specific survival trends through 50 years up to 2020s.

View Article and Find Full Text PDF